PHASE-II STUDY OF SEQUENTIAL METHOTREXATE-5-FU THERAPY IN ADVANCED MEASURABLE COLORECTAL-CANCER
- 1 January 1982
- journal article
- research article
- Vol. 66 (7) , 1563-1565
Abstract
Eighteen patients with previously untreated advanced colorectal cancer were treated with a sequential methotrexate-5-FU [5-flourouracil] regimen. One of 16 evaluable patients achieved a partial response. The results of this and other clinical and laboratory investigations reported to date suggest that further study of different doses and schedules of sequential methotrexate-5-FU is warranted.This publication has 6 references indexed in Scilit:
- Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancerCancer, 1981
- The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells.Journal of Biological Chemistry, 1981
- MODULATION OF 5-FLUOROURACIL METABOLISM AND CYTO-TOXICITY BY ANTI-METABOLITE PRETREATMENT IN HUMAN COLORECTAL ADENOCARCINOMA HCT-81981
- EFFECTIVENESS OF INTERMEDIATE-DOSE METHOTREXATE AND HIGH-DOSE 5-FLUOROURACIL AS SEQUENTIAL COMBINATION CHEMOTHERAPY IN REFRACTORY BREAST-CANCER AND AS PRIMARY THERAPY IN METASTATIC ADENOCARCINOMA OF THE COLON1980
- SCHEDULE-DEPENDENT ANTITUMOR EFFECTS OF METHOTREXATE AND 5-FLUOROURACIL1977
- A phase III study comparing the clinical utility of four regimens of 5-Fluorouracil.A preliminary reportCancer, 1977